Comerica Bank increased its stake in Masimo Co. (NASDAQ:MASI – Get Rating) by 3.4% in the 1st quarter, HoldingsChannel reports. The fund owned 23,749 shares of the medical equipment provider’s stock after acquiring an additional 786 shares during the period. Comerica Bank’s holdings in Masimo were worth $3,235,000 at the end of the most recent quarter.
Several other institutional investors have also added to or reduced their stakes in MASI. Assenagon Asset Management S.A. lifted its stake in Masimo by 1,864.5% in the first quarter. Assenagon Asset Management S.A. now owns 535,812 shares of the medical equipment provider’s stock worth $77,982,000 after purchasing an additional 508,537 shares during the last quarter. Invesco Ltd. raised its stake in shares of Masimo by 12.9% during the fourth quarter. Invesco Ltd. now owns 1,307,606 shares of the medical equipment provider’s stock valued at $382,840,000 after acquiring an additional 149,083 shares in the last quarter. BlackRock Inc. increased its holdings in Masimo by 1.5% during the fourth quarter. BlackRock Inc. now owns 9,026,374 shares of the medical equipment provider’s stock valued at $2,642,740,000 after buying an additional 133,072 shares during the period. Goldman Sachs Group Inc. increased its holdings in Masimo by 62.9% during the fourth quarter. Goldman Sachs Group Inc. now owns 260,047 shares of the medical equipment provider’s stock valued at $76,137,000 after buying an additional 100,388 shares during the period. Finally, JPMorgan Chase & Co. grew its holdings in Masimo by 87.4% in the fourth quarter. JPMorgan Chase & Co. now owns 187,685 shares of the medical equipment provider’s stock worth $54,951,000 after purchasing an additional 87,510 shares during the last quarter. Institutional investors own 92.03% of the company’s stock.
Masimo Price Performance
Masimo stock opened at $138.04 on Thursday. The stock has a market cap of $7.66 billion, a price-to-earnings ratio of 35.67 and a beta of 0.98. The firm has a 50 day simple moving average of $135.00 and a 200-day simple moving average of $159.78. Masimo Co. has a 1-year low of $112.07 and a 1-year high of $305.21.
Masimo (NASDAQ:MASI – Get Rating) last announced its quarterly earnings data on Tuesday, May 3rd. The medical equipment provider reported $0.93 earnings per share for the quarter, beating analysts’ consensus estimates of $0.92 by $0.01. The business had revenue of $304.24 million for the quarter, compared to analyst estimates of $308.04 million. Masimo had a net margin of 17.91% and a return on equity of 15.46%. The company’s revenue was up 1.7% on a year-over-year basis. During the same period last year, the business earned $0.90 EPS. Equities analysts expect that Masimo Co. will post 4.61 earnings per share for the current fiscal year.
Analyst Upgrades and Downgrades
MASI has been the topic of a number of research analyst reports. Piper Sandler dropped their price objective on shares of Masimo from $160.00 to $130.00 in a report on Wednesday, May 4th. Needham & Company LLC reduced their price target on shares of Masimo from $205.00 to $163.00 in a research report on Wednesday, May 4th. Stifel Nicolaus dropped their price objective on shares of Masimo from $175.00 to $150.00 in a research note on Wednesday, May 4th. Wolfe Research started coverage on shares of Masimo in a research note on Tuesday, April 5th. They set a “market perform” rating and a $160.00 price objective for the company. Finally, StockNews.com raised shares of Masimo from a “hold” rating to a “buy” rating in a research note on Wednesday, July 13th. Three equities research analysts have rated the stock with a hold rating and four have given a buy rating to the company’s stock. According to MarketBeat, Masimo presently has a consensus rating of “Moderate Buy” and an average price target of $179.60.
Masimo Company Profile
Masimo Corporation develops, manufactures, and markets noninvasive monitoring technologies and hospital automation solutions worldwide. The company offers masimo signal extraction technology (SET) pulse oximetry with measure-through motion and low perfusion pulse oximetry monitoring to address the primary limitations of conventional pulse oximetry.
See Also
Want to see what other hedge funds are holding MASI? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Masimo Co. (NASDAQ:MASI – Get Rating).
Receive News & Ratings for Masimo Daily – Enter your email address below to receive a concise daily summary of the latest news and analysts’ ratings for Masimo and related companies with MarketBeat.com’s FREE daily email newsletter.
Read More: Comerica Bank Raises Holdings in Masimo Co. (NASDAQ:MASI)